Dose Optimisation of Stavudine for the Treatment of HIV Infection

Clinical trial NCT02670772 · COMPLETED

Trial details

NCT number: NCT02670772
Sponsor: Willem Daniel Francois Venter
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acquired Immune Deficiency Syndrome Human Immunodeficiency Virus

Start date: 2012-07-01
Primary completion: 2014-12-01
Enrollment: 1077

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.